DSC_0221_edited_edited.jpg

Les dernières nouvelles sur Statera Medical et l'industrie de l'orthopédie.

Why We Invested in Statera: The Next Generation of Shoulder Prostheses

2021 October

Statera fabrique des épaules artificielles «connectées»

2021 October

Une prothèse d’épaule connectée développée par des Québécois

2021 July

Bourses Pierre-Péladeau : Québecor remet 200 000 $ pour soutenir les entrepreneurs universitaires québécois

2021 June

Technology applications in shoulder replacement

2019 July

Deltoid fatigue: a longitudinal assessment of reverse shoulder arthroplasty over time

2021 June

Reverse total shoulder arthroplasty-from the most to the least common complication

2010 September

Problems, complications, reoperations, and revisions in reverse total shoulder arthroplasty: a systematic review

2011 January

Reverse Shoulder Arthroplasty in the United States: A Comparison of National Volume, Patient Demographics, Complications, and Surgical Indications

2015

Reverse shoulder arthroplasty for massive rotator cuff tear: risk factors for poor functional improvement

2015 April

The incidence of shoulder arthroplasty: rise and future projections compared with hip and knee arthroplasty

2020 June

Questions à nos Lauréats Mtl inc. en Sciences de la vie

2021 April

Small businesses across Quebec getting support from top post-secondary students

2021 October

Le 1er prix de 100 000 $ à Statera Medical

2021 June

Management of complications after revision shoulder arthroplasty

2015 January

Revision surgery of reverse shoulder arthroplasty

2013 May

Serious adverse events and lifetime risk of reoperation after elective shoulder replacement.

2019 February

The reverse total shoulder arthroplasty

2007 March

Shoulder arthroplasty in the US Medicare population: a 1-year evaluation of surgical complications, hospital admissions, and revision surgery

2018 March

Yearly Trends in Elective Shoulder Arthroplasty, 2005-2013

2017 August

Analysis of 4063 complications of shoulder arthroplasty reported to the US Food and Drug Administration from 2012 to 2016

2018 March